Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program

Elizabeth J. Parks, J. Bruce German, Paul A. Davis, Edwin N. Frankel, C. Tissa Kappagoda, John C Rutledge, Dianne A. Hyson, Barbara O. Schneeman

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The goal of this investigation was to determine whether participation in an atherosclerosis treatment program would reduce the oxidative susceptibility of LDL from patients with coronary artery disease. The treatment program included intensive exercise therapy, stress management, and consumption of a diet containing 10% fat. The size and antioxidant and lipid contents of LDL particles from 25 patients were analyzed at baseline and after 3 mo of therapy. The susceptibility of LDL to copper-mediated oxidation was measured by a conjugated diene assay and headspace gas chromatography (HSGC). Atherosclerosis treatment significantly reduced plasma total cholesterol and apolipoprotein B concentrations and the molar ratio of LDL cholesterol ester to apolipoprotein B (P < 0.01). The LDL content of α- tocopherol and β-carotene was increased (27% and 17%, respectively, P < 0.04) and the molar ratio of LDL cholesterol ester the sum of LDL α- tocopherol and LDL β-carotene decreased from 159 at baseline to 122 at 3 mo (P < 0.01). The lag phase of LDL conjugated diene formation increased 24%, whereas the maximum rate of oxidation slowed 29% (P < 0.01). As assessed by HSGC, copper-catalyzed formation of volatile lipid oxidation products was reduced 15% (P < 0.007); the reduction in volatiles was correlated with an increase in the α-tocopherol content of LDL (r = 0.48, P < 0.01). The principal determinants of reduced LDL oxidative susceptibility were the particle contents of α-tocopherol and β-carotene. To our knowledge, this is the first report to document a reduction in LDL oxidation in coronary artery disease patients undergoing atherosclerosis-reversal therapy.

Original languageEnglish (US)
Pages (from-to)778-785
Number of pages8
JournalAmerican Journal of Clinical Nutrition
Volume68
Issue number4
StatePublished - Oct 1998

Fingerprint

atherosclerosis
tocopherols
Atherosclerosis
carotenes
apolipoprotein B
cholesteryl esters
oxidation
Tocopherols
low density lipoprotein cholesterol
headspace analysis
therapeutics
gas chromatography
copper
stress management
Carotenoids
Therapeutics
Cholesterol Esters
Apolipoproteins B
Gas Chromatography
LDL Cholesterol

Keywords

  • α-tocopherol, β-carotene
  • Antioxidant
  • Atherosclerosis
  • Coronary artery disease
  • Fatty acid composition
  • LDL
  • Low-density lipoprotein
  • Micronutrients
  • Oxidation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Parks, E. J., German, J. B., Davis, P. A., Frankel, E. N., Kappagoda, C. T., Rutledge, J. C., ... Schneeman, B. O. (1998). Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. American Journal of Clinical Nutrition, 68(4), 778-785.

Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. / Parks, Elizabeth J.; German, J. Bruce; Davis, Paul A.; Frankel, Edwin N.; Kappagoda, C. Tissa; Rutledge, John C; Hyson, Dianne A.; Schneeman, Barbara O.

In: American Journal of Clinical Nutrition, Vol. 68, No. 4, 10.1998, p. 778-785.

Research output: Contribution to journalArticle

Parks, EJ, German, JB, Davis, PA, Frankel, EN, Kappagoda, CT, Rutledge, JC, Hyson, DA & Schneeman, BO 1998, 'Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program', American Journal of Clinical Nutrition, vol. 68, no. 4, pp. 778-785.
Parks, Elizabeth J. ; German, J. Bruce ; Davis, Paul A. ; Frankel, Edwin N. ; Kappagoda, C. Tissa ; Rutledge, John C ; Hyson, Dianne A. ; Schneeman, Barbara O. / Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. In: American Journal of Clinical Nutrition. 1998 ; Vol. 68, No. 4. pp. 778-785.
@article{c343c70f370f48b9a911d77b7a570c51,
title = "Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program",
abstract = "The goal of this investigation was to determine whether participation in an atherosclerosis treatment program would reduce the oxidative susceptibility of LDL from patients with coronary artery disease. The treatment program included intensive exercise therapy, stress management, and consumption of a diet containing 10{\%} fat. The size and antioxidant and lipid contents of LDL particles from 25 patients were analyzed at baseline and after 3 mo of therapy. The susceptibility of LDL to copper-mediated oxidation was measured by a conjugated diene assay and headspace gas chromatography (HSGC). Atherosclerosis treatment significantly reduced plasma total cholesterol and apolipoprotein B concentrations and the molar ratio of LDL cholesterol ester to apolipoprotein B (P < 0.01). The LDL content of α- tocopherol and β-carotene was increased (27{\%} and 17{\%}, respectively, P < 0.04) and the molar ratio of LDL cholesterol ester the sum of LDL α- tocopherol and LDL β-carotene decreased from 159 at baseline to 122 at 3 mo (P < 0.01). The lag phase of LDL conjugated diene formation increased 24{\%}, whereas the maximum rate of oxidation slowed 29{\%} (P < 0.01). As assessed by HSGC, copper-catalyzed formation of volatile lipid oxidation products was reduced 15{\%} (P < 0.007); the reduction in volatiles was correlated with an increase in the α-tocopherol content of LDL (r = 0.48, P < 0.01). The principal determinants of reduced LDL oxidative susceptibility were the particle contents of α-tocopherol and β-carotene. To our knowledge, this is the first report to document a reduction in LDL oxidation in coronary artery disease patients undergoing atherosclerosis-reversal therapy.",
keywords = "α-tocopherol, β-carotene, Antioxidant, Atherosclerosis, Coronary artery disease, Fatty acid composition, LDL, Low-density lipoprotein, Micronutrients, Oxidation",
author = "Parks, {Elizabeth J.} and German, {J. Bruce} and Davis, {Paul A.} and Frankel, {Edwin N.} and Kappagoda, {C. Tissa} and Rutledge, {John C} and Hyson, {Dianne A.} and Schneeman, {Barbara O.}",
year = "1998",
month = "10",
language = "English (US)",
volume = "68",
pages = "778--785",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "4",

}

TY - JOUR

T1 - Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program

AU - Parks, Elizabeth J.

AU - German, J. Bruce

AU - Davis, Paul A.

AU - Frankel, Edwin N.

AU - Kappagoda, C. Tissa

AU - Rutledge, John C

AU - Hyson, Dianne A.

AU - Schneeman, Barbara O.

PY - 1998/10

Y1 - 1998/10

N2 - The goal of this investigation was to determine whether participation in an atherosclerosis treatment program would reduce the oxidative susceptibility of LDL from patients with coronary artery disease. The treatment program included intensive exercise therapy, stress management, and consumption of a diet containing 10% fat. The size and antioxidant and lipid contents of LDL particles from 25 patients were analyzed at baseline and after 3 mo of therapy. The susceptibility of LDL to copper-mediated oxidation was measured by a conjugated diene assay and headspace gas chromatography (HSGC). Atherosclerosis treatment significantly reduced plasma total cholesterol and apolipoprotein B concentrations and the molar ratio of LDL cholesterol ester to apolipoprotein B (P < 0.01). The LDL content of α- tocopherol and β-carotene was increased (27% and 17%, respectively, P < 0.04) and the molar ratio of LDL cholesterol ester the sum of LDL α- tocopherol and LDL β-carotene decreased from 159 at baseline to 122 at 3 mo (P < 0.01). The lag phase of LDL conjugated diene formation increased 24%, whereas the maximum rate of oxidation slowed 29% (P < 0.01). As assessed by HSGC, copper-catalyzed formation of volatile lipid oxidation products was reduced 15% (P < 0.007); the reduction in volatiles was correlated with an increase in the α-tocopherol content of LDL (r = 0.48, P < 0.01). The principal determinants of reduced LDL oxidative susceptibility were the particle contents of α-tocopherol and β-carotene. To our knowledge, this is the first report to document a reduction in LDL oxidation in coronary artery disease patients undergoing atherosclerosis-reversal therapy.

AB - The goal of this investigation was to determine whether participation in an atherosclerosis treatment program would reduce the oxidative susceptibility of LDL from patients with coronary artery disease. The treatment program included intensive exercise therapy, stress management, and consumption of a diet containing 10% fat. The size and antioxidant and lipid contents of LDL particles from 25 patients were analyzed at baseline and after 3 mo of therapy. The susceptibility of LDL to copper-mediated oxidation was measured by a conjugated diene assay and headspace gas chromatography (HSGC). Atherosclerosis treatment significantly reduced plasma total cholesterol and apolipoprotein B concentrations and the molar ratio of LDL cholesterol ester to apolipoprotein B (P < 0.01). The LDL content of α- tocopherol and β-carotene was increased (27% and 17%, respectively, P < 0.04) and the molar ratio of LDL cholesterol ester the sum of LDL α- tocopherol and LDL β-carotene decreased from 159 at baseline to 122 at 3 mo (P < 0.01). The lag phase of LDL conjugated diene formation increased 24%, whereas the maximum rate of oxidation slowed 29% (P < 0.01). As assessed by HSGC, copper-catalyzed formation of volatile lipid oxidation products was reduced 15% (P < 0.007); the reduction in volatiles was correlated with an increase in the α-tocopherol content of LDL (r = 0.48, P < 0.01). The principal determinants of reduced LDL oxidative susceptibility were the particle contents of α-tocopherol and β-carotene. To our knowledge, this is the first report to document a reduction in LDL oxidation in coronary artery disease patients undergoing atherosclerosis-reversal therapy.

KW - α-tocopherol, β-carotene

KW - Antioxidant

KW - Atherosclerosis

KW - Coronary artery disease

KW - Fatty acid composition

KW - LDL

KW - Low-density lipoprotein

KW - Micronutrients

KW - Oxidation

UR - http://www.scopus.com/inward/record.url?scp=0031657309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031657309&partnerID=8YFLogxK

M3 - Article

C2 - 9771854

AN - SCOPUS:0031657309

VL - 68

SP - 778

EP - 785

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 4

ER -